Por: Associated Press Business January 31, 2023
Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment.The drugmaker also released an earnings forecast that starts off below analyst expectations, sending shares lower before the opening bell Tuesday. Pfizer expects sales of both the vaccine Comirnaty and the treatment Paxlovid to tumble next year before starting to rebound. That drop was anticipated by... + full article
Newsweek USA Business February 06, 2023
Pfizer's involvement with the 2023 Grammy Awards sparked speculation online, with some viewers wondering how much input the pharmaceutical company had.The annual music ceremony was held at the Crypto.com Arena in Los Angeles, California on Sunday night, with Beyoncé... + más
Here's how to watch the 2023 Grammys on iPhone, iPad, Apple TV, and more | 9to5Mac
Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy. | MarketWatch
MarketWatch USA Business February 04, 2023
Pfizer stock, too, has fallen out of favor, along with other Covid plays. At $44, it’s down 15% this year, making it one of the worst performers in the index. And it’s 30% below its late 2021 peak, badly trailing the rest of the drug group. Now looks like the time to buy... + más
Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
10 WBNS USA Nation October 22, 2022
WASHINGTON — Pfizer will charge $110 to $130 for a dose of its once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. Pfizer executives said the commercial pricing for adult doses could start early... + más
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S. | Fox Business
Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News
Associated Press USA Science October 22, 2022
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free.Pfizer executives said the commercial pricing for adult doses could start early... + más
ABC News USA Business October 21, 2022
ABC News USA Health October 21, 2022
WPLG Local 10 USA Health October 21, 2022
About iurex | Privacy Policy | Disclaimer |